Hyaluronan: towards novel anti-cancer therapeutics (Q38176587)

30 August 2017

Hyaluronan: towards novel anti-cancer therapeutics (English)

1 reference

30 August 2017

Michał S Karbownik

1

1 reference

PubMed ID

24399703

30 August 2017

Jerzy Z Nowak

series ordinal

2

1 reference

30 August 2017

1 January 2013

1 reference

30 August 2017

Pharmacological Reports

1 reference

30 August 2017

65

1 reference

30 August 2017

5

1 reference

30 August 2017

1056-1074

1 reference

Glycosaminoglycans: key players in cancer cell biology and treatment

30 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

Inhibition of hyaluronan retention by 4-methylumbelliferone suppresses osteosarcoma cells in vitro and lung metastasis in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

Expression of CD 44 s, CD 44 v 3 and CD 44 v 6 in benign and malignant breast lesions: correlation and colocalization with hyaluronan

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

The impact of extracellular matrix on the chemoresistance of solid tumors--experimental and clinical results of hyaluronidase as additive to cytostatic chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

Targeting hyaluronidase for cancer therapy: antitumor activity of sulfated hyaluronic acid in prostate cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

Hyaluronan synthase 2 (HAS2) promotes breast cancer cell invasion by suppression of tissue metalloproteinase inhibitor 1 (TIMP-1)

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

Spontaneous metastasis of prostate cancer is promoted by excess hyaluronan synthesis and processing

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

Involvement of hyaluronidases in colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

Hyaluronan-CD44 interaction stimulates Rac1 signaling and PKN gamma kinase activation leading to cytoskeleton function and cell migration in astrocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

CD44 interaction with Na+-H+ exchanger (NHE1) creates acidic microenvironments leading to hyaluronidase-2 and cathepsin B activation and breast tumor cell invasion

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

Hyaluronan-CD44 interaction promotes c-Src-mediated twist signaling, microRNA-10b expression, and RhoA/RhoC up-regulation, leading to Rho-kinase-associated cytoskeleton activation and breast tumor cell invasion

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

Expression of recombinant hyaluronan synthase (HAS) isoforms in CHO cells reduces cell migration and cell surface CD44

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

Differential effect of molecular size HA in mouse chondrocytes stimulated with PMA.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

Molecular characterization of kidney cancer: association of hyaluronic acid family with histological subtypes and metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

PEGylation of hyaluronic acid nanoparticles improves tumor targetability in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

Hyaluronic acid-based nanocarriers for intracellular targeting: interfacial interactions with proteins in cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

CD44s expression in human colon carcinomas influences growth of liver metastases

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

The six hyaluronidase-like genes in the human and mouse genomes

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

Evaluation of angiogenic activities of hyaluronan oligosaccharides of defined minimum size

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

Reversal effects of hyaluronan oligosaccharides on adriamycin resistance of K562/A02 cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

De novo expression of CD44 variants in sporadic and hereditary gastric cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

Genome integrity, stem cells and hyaluronan

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

Hyaluronidase splice variants are associated with histology and outcome in adenocarcinoma and squamous cell carcinoma of the lung.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

Characterization of the expression of variant and standard CD44 in prostate cancer cells: identification of the possible molecular mechanism of CD44/MMP9 complex formation on the cell surface

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

CD44 is of Functional Importance for Colorectal Cancer Stem Cells

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

Detection of hyaluronidase RNA and activity in urine of schistosomal and non-schistosomal bladder cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

Intracellular hyaluronan in arterial smooth muscle cells: association with microtubules, RHAMM, and the mitotic spindle

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

Expression of tumor markers hyaluronic acid and hyaluronidase (HYAL1) in head and neck tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

HYAL1LUCA-1, a candidate tumor suppressor gene on chromosome 3p21.3, is inactivated in head and neck squamous cell carcinomas by aberrant splicing of pre-mRNA

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

Therapeutic applications of hyaluronan

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

Preparation and characterization of hyaluronan oligosaccharides for angiogenesis study

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

Hyaluronan constitutively regulates ErbB2 phosphorylation and signaling complex formation in carcinoma cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

Hyaluronan oligosaccharides inhibit anchorage-independent growth of tumor cells by suppressing the phosphoinositide 3-kinase/Akt cell survival pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

Hyaluronan-Irinotecan improves progression-free survival in 5-fluorouracil refractory patients with metastatic colorectal cancer: a randomized phase II trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

Hyaluronidase inhibitors: a biological and therapeutic perspective

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

Leukemia-associated antigens are critical for the proliferation of acute myeloid leukemia cells

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

High-dose RHAMM-R3 peptide vaccination for patients with acute myeloid leukemia, myelodysplastic syndrome and multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

RHAMM (CD168) is overexpressed at the protein level and may constitute an immunogenic antigen in advanced prostate cancer disease

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

The hyaluronan receptors CD44 and Rhamm (CD168) form complexes with ERK1,2 that sustain high basal motility in breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

Intracellular hyaluronan: a new frontier for inflammation?

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

Significance of CD44v6 expression in gynecologic malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

Hyaluronic acid cues for functional endothelialization of vascular constructs

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

Simple primary structure, complex turnover regulation and multiple roles of hyaluronan

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

Altered hyaluronan biosynthesis in cancer progression

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

Expression of hyaluronan synthase 2 or hyaluronidase 1 differentially affect the growth rate of transplantable colon carcinoma cell tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

Hyaluronan in tissue injury and repair

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

Metastasis suppression: the evolving role of metastasis suppressor genes for regulating cancer cell growth at the secondary site

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

Hyaluronidase as additive to induction chemotherapy in advanced squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

Hyaluronic acid: a natural biopolymer with a broad range of biomedical and industrial applications.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

Butyrate-induced alterations of phosphoinositide metabolism, protein kinase C activity and reduced CD44 variant expression in HT-29 colon cancer cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

Role of receptor for hyaluronic acid-mediated motility (RHAMM) in low molecular weight hyaluronan (LMWHA)-mediated fibrosarcoma cell adhesion

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

Enhanced membrane-type 1 matrix metalloproteinase expression by hyaluronan oligosaccharides in breast cancer cells facilitates CD44 cleavage and tumor cell migration

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

Downregulation of BRG-1 repressed expression of CD44s in cervical neuroendocrine carcinoma and adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

Inhibition of hyaluronan synthase-3 decreases subcutaneous colon cancer growth in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

Preclinical pharmacokinetics of radiolabelled hyaluronan

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

Hyal2--less active, but more versatile?

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

Microbial production of hyaluronic acid: current state, challenges, and perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

HYAL1 hyaluronidase in prostate cancer: a tumor promoter and suppressor

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

Antitumor activity of hyaluronic acid synthesis inhibitor 4-methylumbelliferone in prostate cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

Stromal and epithelial expression of tumor markers hyaluronic acid and HYAL1 hyaluronidase in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

Hyalurondiase: both a tumor promoter and suppressor

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

CD44 attenuates metastatic invasion during breast cancer progression

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

Epididymal SPAM1 and its impact on sperm function.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

7q31-32 allelic loss is a frequent finding in splenic marginal zone lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

Cell-surface and mitotic-spindle RHAMM: moonlighting or dual oncogenic functions?

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

RHAMM expression and isoform balance predict aggressive disease and poor survival in multiple myeloma.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

Regulation of MDR1 expression and drug resistance by a positive feedback loop involving hyaluronan, phosphoinositide 3-kinase, and ErbB2.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

Delivery of CD44 shRNA/nanoparticles within cancer cells: perturbation of hyaluronan/CD44v6 interactions and reduction in adenoma growth in Apc Min/+ MICE.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

Hyaluronan-CD44 interactions as potential targets for cancer therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

Hyaluronan constitutively regulates activation of COX-2-mediated cell survival activity in intestinal epithelial and colon carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

Hyaluronan constitutively regulates activation of multiple receptor tyrosine kinases in epithelial and carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

The influence of hyaluronic acid on vascular endothelial cell proliferation and the relationship with ezrin/merlin expression

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

Reactive oxygen species and hyaluronidase 2 regulate airway epithelial hyaluronan fragmentation

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

Coexpression of CD44 variant isoforms and receptor for hyaluronic acid-mediated motility (RHAMM, CD168) is an International Prognostic Index and C-MYC gene status-independent predictor of poor outcome in diffuse large B-cell lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

4-methylumbelliferone, a hyaluronan synthase suppressor, enhances the anticancer activity of gemcitabine in human pancreatic cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

Involvement of CD44, a molecule with a thousand faces, in cancer dissemination.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

Hyaluronan synthases (HAS1-3) and hyaluronidases (HYAL1-2) in the accumulation of hyaluronan in endometrioid endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

Proteolytic cleavage of the CD44 adhesion molecule in multiple human tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

Hyaluronan synthase HAS2 promotes tumor progression in bone by stimulating the interaction of breast cancer stem-like cells with macrophages and stromal cells

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

CD44, a therapeutic target for metastasising tumours

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

Adhesion proteins meet receptors: a common theme?

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

Hyaluronic acid promotes angiogenesis by inducing RHAMM-TGFβ receptor interaction via CD44-PKCδ.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

Screening of peptides bound to breast cancer stem cell specific surface marker CD44 by phage display

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

In vivo angiogenesis effect of porous collagen scaffold with hyaluronic acid oligosaccharides

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

Antitumor effects of hyaluronic acid inhibitor 4-methylumbelliferone in an orthotopic hepatocellular carcinoma model in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

Hyaluronidase additional to standard chemotherapy improves outcome for children with malignant brain tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

Anticancer therapeutics: targeting macromolecules and nanocarriers to hyaluronan or CD44, a hyaluronan receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

Hyaluronate is synthesized at plasma membranes

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

Network modeling links breast cancer susceptibility and centrosome dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

Anti-CD44 induces apoptosis in T lymphoma via mitochondrial depolarization

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

HYTAD1-p20: a new paclitaxel-hyaluronic acid hydrosoluble bioconjugate for treatment of superficial bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

Functional analysis of the microtubule-interacting transcriptome

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

Overexpression of the receptor for hyaluronan-mediated motility, correlates with expression of microtubule-associated protein in human oral squamous cell carcinomas.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

Hyaluronidase reduces human breast cancer xenografts in SCID mice

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

Concurrent expression of hyaluronan biosynthetic and processing enzymes promotes growth and vascularization of prostate tumors in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

Hyaluronan and hyaluronidase in genitourinary tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

Hyaluronan in human malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

Hyaluronan-mediated angiogenesis in vascular disease: uncovering RHAMM and CD44 receptor signaling pathways

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

Association between cancer and "acid mucopolysaccharides": an old concept comes of age, finally

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

Hyaluronidases in cancer biology

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

Hyaluronan fragments: an information-rich system

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

Hyaluronidases: their genomics, structures, and mechanisms of action

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

Tumor cells enhance their own CD44 cleavage and motility by generating hyaluronan fragments

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

Hyaluronan fragments induce endothelial cell differentiation in a CD44- and CXCL1/GRO1-dependent manner

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

Upregulation of HYAL1 expression in breast cancer promoted tumor cell proliferation, migration, invasion and angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

How does a protein with dual mitotic spindle and extracellular matrix receptor functions affect tumor susceptibility and progression?

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

Inhibition of hyaluronan synthase-3 decreases subcutaneous colon cancer growth by increasing apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

RHAMM promotes interphase microtubule instability and mitotic spindle integrity through MEK1/ERK1/2 activity

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

Rhamm-/- fibroblasts are defective in CD44-mediated ERK1,2 motogenic signaling, leading to defective skin wound repair

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

Hyaluronan: from extracellular glue to pericellular cue.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

Hyaluronan-CD44 Interactions in Cancer: Paradoxes and Possibilities

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

Hyaluronan oligosaccharides as a potential anticancer therapeutic

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

Binding of hyaluronate to the surface of cultured cells

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

Therapeutic potential of hyaluronan oligosaccharides for bone metastasis of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

Inhibition of hyaluronan synthesis in breast cancer cells by 4-methylumbelliferone suppresses tumorigenicity in vitro and metastatic lesions of bone in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

DNA vaccination with CD44 variant isoform reduces mammary tumor local growth and lung metastasis.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

CD44 variant isoforms in head and neck squamous cell carcinoma progression

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

CD44 mediates oligosaccharides of hyaluronan-induced proliferation, tube formation and signal transduction in endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

Versican induces a pro-metastatic ovarian cancer cell behavior which can be inhibited by small hyaluronan oligosaccharides

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

Targeting the tumor microenvironment in cancer: why hyaluronidase deserves a second look

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

Subtype specific elevated expression of hyaluronidase-1 (HYAL-1) in epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

Tumor suppressor genes on chromosome 3p involved in the pathogenesis of lung and other cancers

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

Inhibition of tumor growth in vivo by hyaluronan oligomers.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

Interaction between CD44 and the repeat domain of ankyrin promotes hyaluronic acid-mediated ovarian tumor cell migration

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971465-8

7 January 2021

10.1016/S1734-1140(13)71465-8

Identifiers

DOI

1 reference

30 August 2017

1 reference

PubMed ID

24399703